- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03942627
Promoting Maternal Mental Health and Wellbeing in Neonatal Intensive Care
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
An estimated 400,000-480,000 infants in the U.S. with serious medical conditions are cared for in neonatal intensive care units (NICUs) each year. Maternal stress exposure related to infants' NICU stays is an under-appreciated public health problem with negative implications for maternal and child health and wellbeing. Flexible, effective intervention strategies have potential to improve maternal mental health and parenting, promoting positive emotional and behavioral outcomes for both mothers and infants.
In the investigators' successful pilot research, the investigators developed an audio-delivered mindfulness program to help NICU mothers reduce rumination and worry, cultivate a state of calm awareness, and promote self care. In this small randomized pilot study, the investigators will randomly assign mothers with an infant in the neonatal intensive care unit (NICU) to receive either the mindfulness intervention or an active control program (audio-delivered education on infant care and development).
This study will evaluate feasibility of all key research aspects, including recruitment, randomization, intervention and control conditions, and assessments, in preparation for a future larger-scale study. This study will also assess preliminary intervention outcomes to identify potential program benefits.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21205
- Johns Hopkins University
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- female
- 18 to 50 years old
- mother of an infant currently being treated in the Johns Hopkins Hospital or Johns Hopkins Bayview Medical Center NICU
- able to speak English
Exclusion Criteria:
- known to have serious psychopathology
- infant medically unstable/ progress is poor
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Mindfulness Program
The intervention consists of an introductory video in which a mindfulness expert explains the program's approach and models practices to increase women's comfort with the material, four audio-recorded mindfulness practices for mothers' use when the baby is in the NICU, each available in 5- and 10-minute versions, and a brief video and four additional audio mindfulness practices (each available in briefer and longer versions) for use by mothers during and following the transition home with the baby.
|
The intervention consists of two brief videos (one introducing the NICU portion of the program and one introducing the portion of the program addressing the transition home), as well as a series of mindfulness practices delivered via audio recordings to assist mothers in managing stress during the NICU stay and another series for the transition home.
|
|
Placebo komparator: Infant Health Education Program
The intervention consists of an introductory video explaining the program's approach, four audio recordings providing education about infant health and development, each available in 5- and 10-minute versions, and a brief video and four additional educational recordings (each available in briefer and longer versions) for use by mothers during and following the transition home with the baby.
|
The active control condition consists of two brief videos (one introducing the NICU portion of the program and one introducing the portion of the program addressing the transition home), as well as a series of audio recordings providing information on infant health and development for mothers to use during the NICU stay and another series for the transition home.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Depressive symptoms as assessed by the Patient Health Questionnaire (PHQ)-8
Tidsramme: 2 weeks
|
Self-reported depressive symptoms over the last 2 weeks.
Each of the 8 items is scored 0 (not at all) to 3 (nearly every day), yielding a total between 0 and 24.
Higher scores mean more depressive symptoms.
|
2 weeks
|
|
Anxiety symptoms as assessed by the Generalized Anxiety Disorder - 7 (GAD-7)
Tidsramme: 2 weeks
|
Self-reported anxiety symptoms over the last 2 weeks.
Each of the 7 items is rated from 0 (not at all) to 3 (nearly every day), yielding a total between 0 and 21.
Higher scores mean more anxiety.
|
2 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Trauma symptoms as assessed by the Stanford Acute Stress Reaction Questionnaire (SASRQ)
Tidsramme: 2 weeks
|
31-item self-report measure of trauma symptoms.
Items 1-30 are rated from 0 (not experienced) to 5 (very often experienced).
Item 31 asks how many days symptoms were experienced since giving birth, ranging from no days to 5 or more days.
Higher scores mean more frequent experience of trauma symptoms.
|
2 weeks
|
|
Perceived stress as assessed by the Perceived Stress Scale - NICU (PSS-NICU)
Tidsramme: Up to 2 weeks
|
Self-report measure of perceived stress related to the NICU containing 4 sub scales, each with items rated on a scale of 1 (not at all stressful) to 5 (very stressful).
Higher scores mean more stress.
|
Up to 2 weeks
|
|
Sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI)
Tidsramme: 4 weeks
|
Self-reported measure assessing sleep quality
|
4 weeks
|
|
Coping as assessed by the Brief Cope Scale
Tidsramme: Up to 2 weeks
|
28-item self-reported measure of coping strategies.
Items are rated on a scale ranging from 1 ("I usually don't do this at all") to 4 ("I usually do this a lot")
|
Up to 2 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Erica Sibinga, M.D., Ph.D., Johns Hopkins University
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- IRB00159072
- R34AT009615 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .